NanoViricides, Inc., a publicly traded company (NYSE American:NNVC) (the "Company"), announced that its clinical lead drug NV ...
Cidara’s lead candidate, CD388, is a long-acting antiviral prophylactic designed for universal prevention of seasonal and ...
Visalia Times-Delta on MSN
Tulare veterinarian discovers promising avian flu treatment for cats
A new study of avian flu in cats focuses on a potentially life-saving discovery by veterinarian Dr. Jake Gomez, who treated ...
Roche on Thursday launched direct-to-consumer U.S. sales of its influenza antiviral pill Xofluza at a discounted cash price ...
Midland Reporter-Telegram on MSN
How to spot flu symptoms, stop the spread and get protected
Learn flu symptoms, how it spreads, when you’re contagious, plus testing, antivirals and annual vaccines, including high-dose ...
But a new published case suggests that death may be averted if infected cats are treated early with antiviral medications, ...
The Food and Drug Administration has granted Breakthrough Therapy designation to CD388 for seasonal influenza prevention.
NanoViricides, Inc. (NYSE American:NNVC) (the "Company"), reports that an analyst research report was published on the ...
Flu, COVID-19, the common cold and RSV have similarities, but they differ in their severity, contagiousness and symptoms.
India's Glenmark Pharmaceuticals Ltd said on Friday its clinical trial testing a combination of the antiviral drugs umifenovir and favipiravir in moderate hospitalized COVID-19 patients did not show ...
North Carolina reports its first flu death of the season and urges vaccinations and hygiene to prevent more cases.
Cidara announced Thursday that it received a breakthrough therapy designation from the FDA for an investigational long-acting ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results